Skip to main content
TipRanks
Go Ultimate75% OFF

David George Lowe Insider Profile

4 Followers

David George Lowe, CEO and President, Director at Spyre Therapeutics, holds ― shares in Spyre Therapeutics (Ticker: SYRE), holds 129.60K shares in Oruka Therapeutics (Ticker: ORKA).

David George Lowe's Trading History

ORKA
Oruka Therapeutics
Jul 22, 2009DirectorInformative Sell866.29K$12.86M
SYRE
Spyre Therapeutics
―CEO and President, Director――

You May Also Like

David George Lowe insider profile FAQ

What is the percentage of profitable transactions made by David George Lowe?
The percentage of profitable transactions made by David George Lowe is 25%.
What is the average return per transaction made by David George Lowe?
The average return per transaction made by David George Lowe is -9.60%.
What stocks does David George Lowe hold?
David George Lowe holds: SYRE, ORKA stocks.
What was David George Lowe's most profitable transaction?
David George Lowe’s most profitable transaction was an Informative Sell of ORKA stock on July 22, 2009. The return on the trade was 3.20%.
What is David George Lowe's role in Spyre Therapeutics?
David George Lowe's role in Spyre Therapeutics is CEO and President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.